The US joins Moldova, Hong Kong, and New Zealand as countries to greenlight the company's Phase I trial of PBGENE-HBV.

PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a newly published study in Nature Communications unveiling a powerful new method for ...

Detailed price information for Pacific Biosciences (PACB-Q) from The Globe and Mail including charting and trades.

Pacific Biosciences of California (PACB) ended the recent trading session at $1.22, demonstrating a +1.67% swing from the preceding day's closing price. The stock's change was less than the S&P 500's ...

Government and private funding for genomic research is the key factor driving market revenue growth. According to the Alzheimer’s Disease International, As of June 2024, it is anticipated that more ...